CorMedix Inc. (CRMD) › Total LiabilitiesCorMedix Inc. (CRMD) — Total LiabilitiesAnnual figures by period end, from SEC filings.2010-12-31: $1.59M2011-12-31: $1.22M2012-12-31: $1.49M2013-12-31: $6.99M2014-12-31: $1.46M2015-12-31: $3.09M2016-12-31: $4.09M2017-12-31: $6.26M2018-12-31: $13.89M2019-12-31: $5.83M2020-12-31: $5.09M2021-12-31: $6.15M2022-12-31: $6.98M2023-12-31: $11.92M2024-12-31: $34.19M2025-12-31: $420.83M$420.83M2010-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$420.83M+1130.9%2026-03-05Balance as of period end2024-12-31$34.19M+186.9%2026-03-05Balance as of period end2023-12-31$11.92M+70.8%2025-03-25Balance as of period end2022-12-31$6.98M+13.5%2024-03-12Balance as of period end2021-12-31$6.15M+20.9%2023-03-30Balance as of period end2020-12-31$5.09M-12.8%2022-03-29Balance as of period end2019-12-31$5.83M-58.0%2021-03-30Balance as of period end2018-12-31$13.89M+121.9%2020-03-16Balance as of period end2017-12-31$6.26M+53.0%2019-05-29Balance as of period end2016-12-31$4.09M+32.4%2018-03-19Balance as of period end2015-12-31$3.09M+111.2%2017-03-16Balance as of period end2014-12-31$1.46M-79.1%2016-03-15Balance as of period end2013-12-31$6.99M+369.6%2015-03-12Balance as of period end2012-12-31$1.49M+21.6%2014-03-31Balance as of period end2011-12-31$1.22M-23.1%2014-03-04Balance as of period end2010-12-31$1.59M—2012-04-26Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)